Panbela Therapeutics Inc. (PBLA) vs Virax Biolabs Group Limited (VRAX)

Panbela Therapeutics Inc. and Virax Biolabs Group Limited are both Biotechnology companies. Panbela Therapeutics Inc. and Virax Biolabs Group Limited are of similar size ($3.4M and $3.3M). Across the 8 metrics below, Panbela Therapeutics Inc. leads on 4 and Virax Biolabs Group Limited on 4.

Valuation

Metric PBLA VRAX Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.86 0.74
EV/Sales n/m n/m 10.73
Earnings yield (711,300.00%) (222.08%) (28.84%)
Free cash flow yield (29,656.02%) 0.00% (23.03%)

Profitability

Metric PBLA VRAX Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 270.37% 0.00% (57.72%)
Return on assets (353.47%) 0.00% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PBLA VRAX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 99.43% 68.79% —
Revenue growth, 5-year CAGR — (36.88%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PBLA VRAX Biotechnology median
Debt to equity (0.23) 0.00 0.00
Current ratio 0.26 9.97 4.73
Net debt to EBITDA (0.10) 1.08 0.96

Dividend

Metric PBLA VRAX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric PBLA VRAX Biotechnology median
Market cap 3.35m 3.28m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack